Unleashing Ascl1: Exploring Cross-Lineage Potential in Reprogramming and Regenerative Frontiers

Cell Reprogram. 2023 Aug;25(4):139-141. doi: 10.1089/cell.2023.0080.

Abstract

In the era of stem cell research and regenerative medicine, understanding the regulatory networks that drive cellular reprogramming is fundamental. The study entitled "Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes" published in Stem Cell Reports sheds light on the remarkable versatility of Ascl1, a transcription factor known for its pivotal role in neurogenesis. By comparing regulatomes across multiple cell lineages, the authors have elucidated the potential of Ascl1 to facilitate the conversion of non-neural cells into various lineages beyond its canonical neural fate, suggesting its potential as a master regulator for lineage reprogramming. These observations challenge our current understanding of cell fate determination and open exciting avenues for regenerative medicine.

Keywords: Ascl1; Mef2c; direct reprogramming; epigenetics; regulator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Cell Lineage
  • Cellular Reprogramming*
  • Neurogenesis*
  • Regenerative Medicine